This inventor holds 2 USPTO granted patents. Top assignee: Lupin, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pune, IN (2015)
- Maharashtra, IN (2015)
Company Filing History:
Years Active: 2015
Title: Amol Deshmukh: Innovator in Pharmaceutical Processes
Introduction
Amol Deshmukh is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of darunavir and its derivatives. With a total of 2 patents to his name, Deshmukh's work is recognized for its innovative approaches to drug formulation.
Latest Patents
Deshmukh's latest patents focus on a novel process for the preparation of darunavir and darunavir ethanolate of fine particle size. The invention involves the reduction of a specific carbamic acid ester, leading to the production of darunavir with particle sizes less than 130 µm, 30 µm, and 10 µm. This advancement is crucial for enhancing the efficacy and delivery of the drug.
Career Highlights
Amol Deshmukh is currently employed at Lupin, Inc., a leading pharmaceutical company. His work at Lupin has allowed him to explore and develop innovative processes that contribute to the company's portfolio of medications. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Deshmukh has collaborated with notable colleagues such as Vijay Ahire and Devendra Verma. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Amol Deshmukh's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an innovator. His work continues to impact the development of effective drug formulations, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
